| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ACKNOWLEDGEMENTS
|
|
|
2006
|
24 |
S3 |
p. xiii-
1 p.
|
article
|
| 2 |
Chapter 7: Achievements and limitations of cervical cytology screening
|
Kitchener, Henry C.
|
|
2006
|
24 |
S3 |
p. S63-S70
8 p.
|
article
|
| 3 |
Chapter 22: Assuring the quality, safety and efficacy of HPV vaccines: The scientific basis of regulatory expectations pre- and post-licensure
|
Wood, David
|
|
2006
|
24 |
S3 |
p. S187-S192
6 p.
|
article
|
| 4 |
Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease
|
Lacey, Charles J.N.
|
|
2006
|
24 |
S3 |
p. S35-S41
7 p.
|
article
|
| 5 |
Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses
|
Arbyn, Marc
|
|
2006
|
24 |
S3 |
p. S78-S89
12 p.
|
article
|
| 6 |
Chapter 19: Cost-effectiveness of cervical cancer screening
|
Goldie, Sue J.
|
|
2006
|
24 |
S3 |
p. S164-S170
7 p.
|
article
|
| 7 |
Chapter 13: Current findings from prophylactic HPV vaccine trials
|
Koutsky, Laura A.
|
|
2006
|
24 |
S3 |
p. S114-S121
8 p.
|
article
|
| 8 |
Chapter 25: Education, training, and communication for HPV vaccines
|
Sherris, Jacqueline
|
|
2006
|
24 |
S3 |
p. S210-S218
9 p.
|
article
|
| 9 |
Chapter 6: Epidemiology and transmission dynamics of genital HPV infection
|
Burchell, Ann N.
|
|
2006
|
24 |
S3 |
p. S52-S61
10 p.
|
article
|
| 10 |
Chapter 1: HPV in the etiology of human cancer
|
Muñoz, Nubia
|
|
2006
|
24 |
S3 |
p. S1-S10
10 p.
|
article
|
| 11 |
Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases
|
Clifford, Gary
|
|
2006
|
24 |
S3 |
p. S26-S34
9 p.
|
article
|
| 12 |
Chapter 14: HPV vaccine introduction in industrialized countries
|
Wright, Thomas C.
|
|
2006
|
24 |
S3 |
p. S122-S131
10 p.
|
article
|
| 13 |
Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts
|
Wright, Thomas C.
|
|
2006
|
24 |
S3 |
p. S251-S261
11 p.
|
article
|
| 14 |
Chapter 11: HPV vaccines: Commercial Research & Development
|
Inglis, Stephen
|
|
2006
|
24 |
S3 |
p. S99-S105
7 p.
|
article
|
| 15 |
Chapter 16: HPV vaccines in immunocompromised women and men
|
Palefsky, Joel M.
|
|
2006
|
24 |
S3 |
p. S140-S146
7 p.
|
article
|
| 16 |
Chapter 15: HPV vaccine use in the developing world
|
Kane, Mark A.
|
|
2006
|
24 |
S3 |
p. S132-S139
8 p.
|
article
|
| 17 |
Chapter 26: Innovative financing mechanisms to accelerate the introduction of HPV vaccines in developing countries
|
Batson, Amie
|
|
2006
|
24 |
S3 |
p. S219-S225
7 p.
|
article
|
| 18 |
Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays—an update
|
Pagliusi, Sonia R.
|
|
2006
|
24 |
S3 |
p. S193-S200
8 p.
|
article
|
| 19 |
Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination
|
Franco, Eduardo L.
|
|
2006
|
24 |
S3 |
p. S171-S177
7 p.
|
article
|
| 20 |
Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancer
|
Franco, Eduardo L.
|
|
2006
|
24 |
S3 |
p. S242-S249
8 p.
|
article
|
| 21 |
Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes
|
Garnett, Geoffrey P.
|
|
2006
|
24 |
S3 |
p. S178-S186
9 p.
|
article
|
| 22 |
Chapter 10: New dimensions in cervical cancer screening
|
Cuzick, Jack
|
|
2006
|
24 |
S3 |
p. S90-S97
8 p.
|
article
|
| 23 |
Chapter 12: Prophylactic HPV vaccines: Underlying mechanisms
|
Stanley, Margaret
|
|
2006
|
24 |
S3 |
p. S106-S113
8 p.
|
article
|
| 24 |
Chapter 24: Psychosocial aspects of vaccine acceptability
|
Zimet, Gregory D.
|
|
2006
|
24 |
S3 |
p. S201-S209
9 p.
|
article
|
| 25 |
Chapter 18: Public health policy for cervical cancer prevention: The role of decision science, economic evaluation, and mathematical modeling
|
Goldie, Sue J.
|
|
2006
|
24 |
S3 |
p. S155-S163
9 p.
|
article
|
| 26 |
Chapter 27: Research needs following initial licensure of virus-like particle HPV vaccines
|
Hildesheim, Allan
|
|
2006
|
24 |
S3 |
p. S227-S232
6 p.
|
article
|
| 27 |
Chapter 8: Screening for cervical cancer in developing countries
|
Denny, Lynette
|
|
2006
|
24 |
S3 |
p. S71-S77
7 p.
|
article
|
| 28 |
Chapter 17: Second generation HPV vaccines to prevent cervical cancer
|
Schiller, John T.
|
|
2006
|
24 |
S3 |
p. S147-S153
7 p.
|
article
|
| 29 |
Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries
|
Lehtinen, Matti
|
|
2006
|
24 |
S3 |
p. S233-S241
9 p.
|
article
|
| 30 |
Chapter 2: The burden of HPV-related cancers
|
Parkin, D. Maxwell
|
|
2006
|
24 |
S3 |
p. S11-S25
15 p.
|
article
|
| 31 |
Chapter 5: Updating the natural history of HPV and anogenital cancer
|
Moscicki, Anna-Barbara
|
|
2006
|
24 |
S3 |
p. S42-S51
10 p.
|
article
|
| 32 |
Disclosure of Financial Support
|
|
|
2006
|
24 |
S3 |
p. S263-
1 p.
|
article
|
| 33 |
Editorial Board/Aims and Scope
|
|
|
2006
|
24 |
S3 |
p. CO2-
1 p.
|
article
|
| 34 |
List of Contributors
|
|
|
2006
|
24 |
S3 |
p. vii-ix
nvt p.
|
article
|
| 35 |
Perspectives of contemporary papillomavirus research
|
zur Hausen, Harald
|
|
2006
|
24 |
S3 |
p. iii-iv
nvt p.
|
article
|
| 36 |
Preface
|
Bosch, F. Xavier
|
|
2006
|
24 |
S3 |
p. v-vi
nvt p.
|
article
|
Journal description